cox 189 has been researched along with 2-anilinophenylacetic acid in 2 studies
| Studies (cox 189) | Trials (cox 189) | Recent Studies (post-2010) (cox 189) | Studies (2-anilinophenylacetic acid) | Trials (2-anilinophenylacetic acid) | Recent Studies (post-2010) (2-anilinophenylacetic acid) |
|---|---|---|---|---|---|
| 163 | 49 | 47 | 6 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blobaum, AL; Marnett, LJ | 1 |
| Banerjee, S; Marnett, LJ; Valk, PL; Windsor, MA; Xu, S | 1 |
2 other study(ies) available for cox 189 and 2-anilinophenylacetic acid
| Article | Year |
|---|---|
Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.
Topics: Amino Acid Substitution; Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Humans; Kinetics; Male; Membrane Proteins; Mice; Models, Molecular; Mutation, Missense; Protein Binding; Protein Structure, Tertiary; Sheep; Time Factors | 2007 |
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib.
Topics: Animals; Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diclofenac; Endocannabinoids; Mice; Molecular Docking Simulation | 2013 |